Rationale for a multimodality strategy to enhance the efficacy of dendritic cell-based cancer immunotherapy door Jashodeep eDatta, Erik eBerk, Jessica A Cintolo, Shuwen eXu, Robert E Roses, Brian J Czerniecki

Volledige tekst